Home › Funds › Propel Bio Management, LLC › IVA

Propel Bio Management, LLC position in IVA

INVENTIVA SA · Health Care

Propel Bio Management, LLC reported holding 1,133,954 shares of IVA (INVENTIVA SA) in its Q3 2026 13F filing — a position valued at US$4.2M, representing 2.22% of its reported portfolio and ranking #15 among its reported holdings. Propel Bio Management, LLC has disclosed IVA holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)1.13M sh
Reported value held$4.18M
Portfolio Weight2.22%
First reportedQ4 2025
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Propel Bio Management, LLC's IVA position evolved

Propel Bio Management, LLC first disclosed a stake in IVA in Q4 2025 at 1,000,000 shares (US$4.7M). The position peaked in Q2 2026 at 1,281,212 shares, worth US$4.8M. Across 4 filings, Propel Bio Management, LLC increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,133,954 shares valued at US$4.2M — a reduction of -147,258 shares quarter over quarter.. Notable position changes include a 28% trim in Q1 2026 (shares fell 32% over the following quarter), a 77% increase in Q2 2026 (shares fell 2% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 1.00M $4.65M New
Q1 2026 724.68K $3.99M Reduce
Q2 2026 1.28M $4.84M Add
Q3 2026 1.13M $4.18M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IVA and 13F data

IVA (INVENTIVA SA) is a Health Care company. 88 other funds we track also report a position in IVA — the largest reported positions include Caligan Partners LP (US$30.9M), Samsara BioCapital, LLC (US$23.9M), Paradigm Biocapital Advisors LP (US$15.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IVA

All IVA fund holders →

FAQ

How long has Propel Bio Management, LLC held IVA?

Propel Bio Management, LLC has disclosed IVA holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Propel Bio Management, LLC's current position in IVA?

As of Q3 2026, Propel Bio Management, LLC holds 1.13M shares of IVA (INVENTIVA SA), valued at $4.18M, representing 2.22% of its reported portfolio and ranking #15.

Has Propel Bio Management, LLC been buying or selling IVA?

In the latest 13F filing (Q3 2026), Propel Bio Management, LLC reduced its position in IVA. The position peaked in Q2 2026 at 1.28M shares.

Which other funds hold IVA?

Other major institutional holders of IVA include Caligan Partners LP, Samsara BioCapital, LLC, Paradigm Biocapital Advisors LP, among 88 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.